Education
About Us
Working with TipRanks
Follow Us
Supriya Lifescience Limited (IN:SUPRIYA)
:SUPRIYA
Total Valuation
Supriya Lifescience Limited has a market cap or net worth of ₹54.85B. The enterprise value is ₹14.72B.
Market Cap₹54.85B
Enterprise Value₹14.72B
Share Statistics
Supriya Lifescience Limited has 80,482,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,482,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Supriya Lifescience Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 17.64%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)17.64%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.63
Inventory Turnover2.64
Valuation Ratios
The current PE Ratio of Supriya Lifescience Limited is 0.00. Supriya Lifescience Limited’s PEG ratio is 2.24.
PE Ratio0.00
PS Ratio0.00
PB Ratio6.45
Price to Fair Value0.00
Price to FCF-357.58
Price to Operating Cash Flow81.36
PEG Ratio2.24
Income Statement
In the last 12 months, Supriya Lifescience Limited had revenue of 6.96B and earned 1.88B in profits. Earnings per share was 23.35.
Revenue6.96B
Gross Profit3.84B
Operating Income2.40B
Pretax Income2.48B
Net Income1.88B
EBITDA2.71B
Earnings Per Share (EPS)23.35
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Supriya Lifescience Limited pays an annual dividend of ₹0.8, resulting in a dividend yield of 0.12%
Dividend Per Share₹0.8
Dividend Yield0.12%
Payout Ratio3.78%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change72.42%
50-Day Moving Average694.18
200-Day Moving Average672.60
Relative Strength Index (RSI)46.81
Average Volume (3m)17.07K
Important Dates
Supriya Lifescience Limited upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 27, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateSep 20, 2024
Financial Position
Supriya Lifescience Limited as a current ratio of 5.32, with Debt / Equity ratio of 4.45%
Current Ratio5.32
Quick Ratio3.88
Debt to Market Cap0.00
Net Debt to EBITDA-0.27
Interest Coverage Ratio142.56
Taxes
In the past 12 months, Supriya Lifescience Limited has paid 605.23M in taxes.
Income Tax605.23M
Effective Tax Rate0.24
Enterprise Valuation
Supriya Lifescience Limited EV to EBITDA ratio is -0.27, with an EV/FCF ratio of -7.24.
EV to Sales-0.11
EV to EBITDA-0.27
EV to Free Cash Flow-7.24
EV to Operating Cash Flow-0.43
Balance Sheet
Supriya Lifescience Limited has ₹843.14M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹843.14M billion.
Cash & Marketable Securities₹843.14M
Total Debt₹0.00
Net Cash-₹843.14M
Net Cash Per Share-₹10.48
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 55.74%, with operating margin of 34.51%, and net profit margin of 26.99%.
Gross Margin55.74%
Operating Margin34.51%
Pretax Margin35.68%
Net Profit Margin26.99%
EBITDA Margin38.85%
EBIT Margin35.92%
Analyst Forecast
The average price target for Supriya Lifescience Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―